title: Humanization of an anti-mucin antibody for breast and ovarian cancer therapy.
abstract: Antibody-drug conjugates utilize the targetting potential of antibodies to improve the potential of cytostatic or cytocidal drugs. One such murine monoclonal antibody, CTM01 (mCTM01), which recognizes an epitope on breast epithelial mucin, has potential for the treatment of breast and ovarian cancers. We examine in this paper the comparative properties of mCTM01 against a number of other anti-mucin antibodies. We then describe the humanization and high level re-expression of humanized CTM01 (hCTM01), a process designed to avoid the immune response to administered murine antibodies in human patients and to produce sufficient material for clinical studies. We show that the humanized form has properties superior to mCTM01 in terms of binding affinity to antigen presented on tumour cells.
authors.affiliation: Celltech Research Division, Celltech Ltd., Slough, Berks, U.K.
authors.forename: T S
authors.initials: TS
authors.lastname: Baker
authors.forename: C C
authors.initials: CC
authors.lastname: Bose
authors.forename: H M
authors.initials: HM
authors.lastname: Caskey-Finney
authors.forename: D J
authors.initials: DJ
authors.lastname: King
authors.forename: A D
authors.initials: AD
authors.lastname: Lawson
authors.forename: A
authors.initials: A
authors.lastname: Lyons
authors.forename: A
authors.initials: A
authors.lastname: Mountain
authors.forename: R J
authors.initials: RJ
authors.lastname: Owens
authors.forename: M R
authors.initials: MR
authors.lastname: Rolfe
authors.forename: M
authors.initials: M
authors.lastname: Sehdev
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry* / Q000276:immunology / Q000627:therapeutic use; D000915:Antibody Affinity; D000951:Antigens, Neoplasm / Q000276:immunology*; D001943:Breast Neoplasms / Q000276:immunology* / Q000628:therapy; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008562:Membrane Glycoproteins / Q000276:immunology*; D051379:Mice; D018598:Minisatellite Repeats; D008969:Molecular Sequence Data; D018396:Mucin-1; D009077:Mucins / Q000276:immunology*; D009363:Neoplasm Proteins / Q000276:immunology; D010051:Ovarian Neoplasms / Q000276:immunology* / Q000628:therapy; D010446:Peptide Fragments / Q000276:immunology; D015202:Protein Engineering; D011993:Recombinant Fusion Proteins / Q000737:chemistry* / Q000276:immunology / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D008562:Membrane Glycoproteins; D018396:Mucin-1; D009077:Mucins; D009363:Neoplasm Proteins; D010446:Peptide Fragments; D011993:Recombinant Fusion Proteins